U
IONS icon

UBS’s Ionis Pharmaceuticals IONS Stock Holding History

UBS’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.93M Buy
49,600
+18,300
+58% +$649K ﹤0.01% 2942
2014
Q2 		$1.08M Sell
31,300
-63,000
-67% -$1.98M ﹤0.01% 3470
2014
Q1 		$4.08M Buy
94,300
+50,900
+117% +$2.47M ﹤0.01% 2059
2013
Q4 		$1.73M Sell
43,400
-8,400
-16% -$299K ﹤0.01% 2951
2013
Q3 		$1.95M Sell
51,800
-15,700
-23% -$469K ﹤0.01% 2622
2013
Q2 		$1.81M Buy
+67,500
New +$1.44M ﹤0.01% 2646

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS's IONS Position: Q3 2014 in Review

UBS increased its Ionis Pharmaceuticals (IONS) stake by 28% in Q3 2014, buying an estimated $818K and bringing the position to 104,425 shares worth $4.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2228.

UBS first reported a position in IONS in Q2 2013 and has held it in 6 quarters since. 240 funds tracked by Wall St. Rank hold IONS as of Q3 2014.

  • UBS held 104,425 shares of Ionis Pharmaceuticals worth $4.05M as of Q3 2014.
  • UBS bought 23,071 Ionis Pharmaceuticals shares in Q3 2014, an estimated $818K.
  • Ionis Pharmaceuticals made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2228 holding.
  • UBS first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
  • 240 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.